Brief: FDA Accepts Xspray Request For Type C Meeting On Dasynoc
26/06/2026 07:45
BRIEF-FDA Accepts Xspray Request For Type C Meeting On Dasynoc June 26 (Reuters) - Xspray Pharma publ AB XSPRAY.ST:
FDA ACCEPTS XSPRAY REQUEST FOR TYPE C MEETING ON DASYNOC LABELING ENHANCEMENT
Source text: ID:nMFNbf6dCC
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))